Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
CREAM
**Dosage** Apply the cream one or two times every day (preferably at night or in the morning and at night), mildly and uniformly on the lesion, trying, besides, to embrace 1 cm of sound skin (approximately) around the affected area. The duration of the treatment to obtain the healing, varies from one patient to another, in function of the etiologic agent and location of the infection. In general, four weeks of treatment are recommended to ensure a complete clinical and microbiologic healing and the non appearance of relapses, though, in many cases, this clinical-microbiological healing appears earlier, between two and four weeks of treatment.
TOPICAL
Medical Information
**Indications** Topical treatment of surface skin mycoses, such as dermatophytosis, Tinea pedis (athlete's foot), Tinea cruris (Hebra's eczema), Tinea corporis (herpes circinatus), Tinea barbae (beard mycosis) and Tinea manus, Candidiasis (Moniliasis) and Pityriasis versicolor (Pityrosporum orbiculare, Malassezia furfur formerly).
**Contraindications** Are not known.
D01AC14
sertaconazole
Manufacturer Information
DCH AURIGA SINGAPORE
FERRER INTERNACIONAL SA
Active Ingredients
Documents
Package Inserts
Zalain Cream PI.pdf
Approved: November 2, 2003